Enter Air S.A. (ENT)
Warsaw Stock Exchange · Poland · prices in PLN · close of 23 Oct 2026
Key indicators
| Last close | PLN 48.10 |
|---|---|
| 52-week range | 45.80 – 67.00 |
| Return, 1 month / 3 months | −3.8% / −2.9% |
| Return, 1 year / 3 years | −10.1% / +30.6% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 29.1% |
| Worst drawdown (1 year) | -26.7% |
| Average daily value traded | 0.82M PLN |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Enter Air is a Polish charter airline based in Warsaw. It operates passenger charter flights, mostly on behalf of tour operators, carrying holidaymakers to leisure destinations in Europe and beyond. The airline also runs ad hoc and subservice flights for other carriers and organisations. Its fleet is built around Boeing narrow-body jets, and its operations are centred on Polish airports with seasonal peaks in the summer holiday period.
Enter Air S.A. trades under the code ENT on the Warsaw Stock Exchange in Poland, with its price quoted in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Enter Air S.A. (ENT) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 48.10 on 23 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 262 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.1% and over the last three months it fell 2.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.5% | ||
| From 52-week high | -27.2% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.9% | ||
| 6-month return | -12.2% | ||
| 12-month return, skipping the last month | -6.6% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.7% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 0.82M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | −3.8% |
| 3 months | −2.9% |
| 6 months | −12.2% |
| 1 year | −10.1% |
| 3 years | +30.6% |
| 5 years | +66.5% |
Signals
| 50-day / 200-day average | 50.03 / 52.56 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.25 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | PLN 2.5000 |
| 30 Jun 2025 | PLN 3.0000 |
| 13 Aug 2024 | PLN 4.4000 |
| 4 Jul 2019 | PLN 0.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.